Home » Newsletters » BioWorld

BioWorld

Feb. 1, 1999

View Archived Issues

Underwriters' Performance On All Public Offerings For 1998: Full Credit To All Underwriters, Ranked By After-Market Performance*

Underwriters' Performance On All Public Offerings For 1998: Full Credit To All Underwriters, Ranked By Gross Proceeds*

Underwriters' Performance On All Public Offerings For 1998: Full Credit To Lead Underwriter, Ranked By Gross Proceeds*

Underwriters' Performance On All Public Offerings For 1998: Full Credit To Lead Underwriter, Ranked By After-Market Performance*

Underwriters' Performance On 1998's IPOs: Full Credit To All Underwriters, Ranked By Gross Proceeds*

Underwriters' Performance On 1998's IPOs: Full Credit To All Underwriters, Ranked By After-Market Performance*

Underwriters' Performance On 1998's IPOs: Full Credit To Lead Underwriter, Ranked By Gross Proceeds*

Underwriters' Performance On 1998's IPOs: Full Credit To Lead Underwriter, Ranked By After-Market Performance*

H&Q, Robertson Stephens Top 1998 Underwriters' List

1998 Initial Public Offerings

1998 Follow-On Public Offerings

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 6, 2025.
Regenxbio’s Duchenne gene therapy data positive as shares falter
BioWorld
Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...
EMA warns Ozempic linked to ‘very rare’ side effect
BioWorld
The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which...
Aiatella secures €2M for AI-based cardiovascular imaging tech
BioWorld MedTech
Aiatella Oy secured €2 million (US$2.28 million) in funding for its AI-powered cardiovascular imaging technology. The funds will be used to conduct clinical...